The upregulation of two lncRNAs (LINC00240 and RBMS3-AS3) and the downregulation of one lncRNA (ALG9-IT1) in the findings suggests their potential involvement in the pathogenesis of NAFLD. This evidence concerns the gene ALG9 and metabolic dysfunction-associated steatotic liver disease.